HeyJaredLet's Talk Risk! with Dr. Naveen Agarwal
Every Friday, Dr. Naveen Agarwal leads a Let's Talk Risk! conversation with industry colleagues to discuss practical challenges and share best practices in risk management.
- Indexed pieces, last 90 days
- 26
- Latest publication
- Sep 29, 2026
- Audience
- By platform
- Earliest in this view
- Jul 10, 2026
One publication, every platform
Open a platform to follow it on its own.
Why these are grouped
They share a verified publisher identifier or are linked from the publication’s official site. People stay separate from their publications.
Latest pieces
QMSR QuickTake #44: A Device Can Be “Finished” Before It Is Final (opens the original)
Read excerpt
In responding to Comment #33 in the preamble of the QMSR1, FDA addresses an important boundary question: when is something a component, and when has it become a finished device?That distinction matters because QMSR generally applies directly to manufacturers of finished devices, while manufacturers that only produce components or parts are generally not directly subject to QMSR.<a class="image-link image2 is-viewable-img" href="https://substackcdn.com/image/fetch/$s_!Hl8y!,f_auto,q_auto:good,fl_
TAI #44: The Supplier Risk Traceability Gap (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="630" src="https://substackcdn.com/image/fetch/$s_!1MNj!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb91a314c-cf96-4fb1-98e8-edc2ffdf28ee_1200x630.png"
Deep Dive: When the Risk Baseline and the QMS Both Break Down (opens the original)
Read excerpt
The baseline is completely broken and the iteration process is blind.FDA’s August 21, 2026 warning letter to Pensar Medical LLC illustrates a failure that goes well beyond incomplete documentation.The underlying risk-management foundation was weak. Risk-control verification remained incomplete for critical areas, and FDA reportedly found no design, process, or use-related FMEAs for the WoundPro product line.At the same time, key QMS processes were also failing.Key highlights covered in the audio
QMSR QuickTake #43: QMS Risk Is Broader Than ISO 14971 (opens the original)
Read excerpt
In responding to Comment #32 in the preamble of the QMSR1, FDA pointed manufacturers back to ISO 13485 Clause 0.2 within the standard. The term risk relates to device safety, device performance, and meeting applicable regulatory requirements.<a class="image-link image2 is-viewable-img" href="https://substackcdn.com/image/fetch/$s_!t9bO!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe682122e-d973-416f-ac64-2bbcd41d0097_1080x1350.pn
TAI #43: How Traceable Are Safety-Related Characteristics in Your Risk File? (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="630" src="https://substackcdn.com/image/fetch/$s_!S3Pr!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F17a705dc-1c54-474a-b737-9289ea8034db_1200x630.png"
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Each platform is measured on its own. Audiences can overlap.
Newsletter
No verified audience measurement yet.
Podcast
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.